Boston-based Ginkgo Bioworks Holdings, Inc. (DNA) made its market debut on Sept. 17, 2021, through an SPAC merger with Soaring Eagle Acquisition Corporation. DNA has actively supported several COVID-19 response activities, including K-12 pooled testing, vaccine production optimization, and medicines development
However, the stock has plunged 56.3% in price over the past three months and 10.6% over the past month to close yesterday's trading session at $6.10.
